| NBS | Newborn screening |
| IEM | Inborn errors of metabolism |
| QNGM | Quebec Network of Genetic Medicine |
| DBS | Dried blood spot |
| DUS | Dried urine spot |
| TLC | Thin layer chromatography |
| Triple H | Hyperornithinemia-hyperammonemia-homocitrullinuria |
| QNSP | Quebec Neuroblastoma Screening Project |
| NIH | National Institutes of Health |
| HVA | Homovanillic acid |
| VMA | Vanillylmandelic acid |
| QCs | Quality controls |
| MS/MS | Tandem mass spectrometry |
| LC-MS/MS | Liquid chromatography-tandem mass spectrometry |
| CID | Collision-induced dissociation |
| IS | Internal standard |
| REB | Research Ethics Board |
| CIUSSSE-CHUS | Centre intégré universitaire de santé et de services sociaux de l’Estrie-Centre hospitalier universitaire de Sherbrooke |
| CMMA | Combined malonic and methylmalonic aciduria |
| ASA | Argininosuccinic aciduria |
| HCl | Hydrochloric acid |
| IQA | Internal quality assurance |
| ERNDIM | European Research Network for Evaluation and Improvement of Screening, Diagnosis, and Treatment of Inborn Errors of Metabolism |
| LOQ | Limit of quantitation |
| UHPLC-MS/MS | Ultra-high performance liquid chromatography tandem mass spectrometry |
| MRM | Multiple reaction monitoring |
| RRF | Relative Response Factor |
| LOD | Limits of detection |
| BSTFA | N,O-Bis(trimethylsilyl)trifluoroacetamide |